Effects of Chronic Antihypertensive Therapy on Clinical Outcomes in Septic Shock

Completed

Conditions studied: Atrial Fibrillation, Septic Shock

In brief

Retrospective two-cohort study to determine the effect of chronic antihypertensive therapy on new onset atrial fibrillation and clinical outcomes in septic shock.

Key facts

Study ID

NCT02876341

Run by

Rush University Medical Center

People needed

133

Starts

2016-08-01

Expected to finish

2017-03-31

Last updated by the study team

2017-04-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients 18 years of age or older
• Diagnosis of septic shock requiring vasopressor therapy (norepinephrine, epinephrine, phenylephrine, dopamine, or vasopressin)
• Admitted to the medical intensive care unit (MICU) at Rush University Medical Center (RUMC)
• Time frame: 01/01/2012 to 07/1/2016

You may not qualify if…

• Pregnant patients
• Transfer from outside hospital on vasopressors
• Admitted to MICU in cardiopulmonary arrest
• Prior arrest within 24 hours of admission to RUMC

Where it is running

• Rush Univeristy Medical Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.